CLINICAL_TRIALS
ClinicalTrials.gov record update
Effects of Ertugliflozin on Liver Fat, Liver Fibrosis & Glycemic Control in Subjects With Type 2 Diabetes Mellitus (T2DM) & Non-Alcoholic Fatty Liver Disease /Non-Alcoholic Steatohepatitis
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT05644717
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:26:42.991617+00:00
- Published At
- 2025-03-21T00:00:00+00:00
- Record Updated At
- 2025-03-21
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Liver Fat", "Liver Fibrosis", "Glycemic Control", "Body Weight Changes", "Waist Circumference", "Tolerance"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-03-21"- protocolSection.identificationModule.nctId
"NCT05644717"- protocolSection.identificationModule.officialTitle
"Effects of Ertugliflozin on Liver Fat, Liver Fibrosis \u0026 Glycemic Control in Subjects With Type 2 Diabetes Mellitus (T2DM) \u0026 Non-Alcoholic Fatty Liver Disease /Non-Alcoholic Steatohepatitis"- protocolSection.statusModule.overallStatus
"RECRUITING"- protocolSection.designModule.phases
["PHASE4"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.